Drug design strategies for Cushing ’s syndrome
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 21, 2018 Category: Drugs & Pharmacology Authors: S. A. Usanov A. V. Kliuchenovich N. V. Strushkevich Source Type: research

Organ-on-a-chip technologies that can transform ophthalmic drug discovery and disease modeling
Volume 14, Issue 1, January 2019, Page 47-57 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 8, 2018 Category: Drugs & Pharmacology Authors: Jasmin C. Haderspeck Johanna Chuchuy Stefan Kustermann Stefan Liebau Peter Loskill Source Type: research

Organ-on-a-chip technologies that can transform ophthalmic drug discovery and disease modeling
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 8, 2018 Category: Drugs & Pharmacology Authors: Jasmin C. Haderspeck Johanna Chuchuy Stefan Kustermann Stefan Liebau Peter Loskill Source Type: research

Organ- on -a- chip technologies that can transform ophthalmic drug discovery and disease modeling
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 8, 2018 Category: Drugs & Pharmacology Authors: Jasmin C. Haderspeck Johanna Chuchuy Stefan Kustermann Stefan Liebau Peter Loskill Source Type: research

Lamotrigine as a mood stabilizer: insights from the pre-clinical evidence
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 7, 2018 Category: Drugs & Pharmacology Authors: Aline Silva de Miranda Amanda Silva de Miranda Ant ônio Lúcio Teixeira Source Type: research

Optimization techniques for novel c-Met kinase inhibitors
Volume 14, Issue 1, January 2019, Page 59-69 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 6, 2018 Category: Drugs & Pharmacology Authors: Zhi-Gang Sun Yong-An Yang Zhi-Gang Zhang Hai-Liang Zhu Source Type: research

Optimization techniques for novel c-Met kinase inhibitors
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 6, 2018 Category: Drugs & Pharmacology Authors: Zhi-Gang Sun Yong-An Yang Zhi-Gang Zhang Hai-Liang Zhu Source Type: research

Challenges with risk mitigation in academic drug discovery: finding the best solution
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 4, 2018 Category: Drugs & Pharmacology Authors: Anuradha Roy Source Type: research

Advances with support vector machines for novel drug discovery
Volume 14, Issue 1, January 2019, Page 23-33 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 29, 2018 Category: Drugs & Pharmacology Authors: Vinicius Gon çalves Maltarollo Thales Kronenberger Gabriel Zarzana Espinoza Patricia Rufino Oliveira Kathia Maria Honorio Source Type: research

Drug-based cancer therapy to overcome immune resistance by steering tumor evolution
Volume 14, Issue 1, January 2019, Page 5-8 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 29, 2018 Category: Drugs & Pharmacology Authors: Ariel Fern ández Source Type: research

Closed-loop discovery platform integration is needed for artificial intelligence to make an impact in drug discovery
Volume 14, Issue 1, January 2019, Page 1-4 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 29, 2018 Category: Drugs & Pharmacology Authors: Semion K. Saikin Christoph Kreisbeck Dennis Sheberla Jill S. Becker Aspuru-Guzik A. Source Type: research

Advances with support vector machines for novel drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 29, 2018 Category: Drugs & Pharmacology Authors: Vinicius Gon çalves Maltarollo Thales Kronenberger Gabriel Zarzana Espinoza Patricia Rufino Oliveira Kathia Maria Honorio Source Type: research

Closed-loop discovery platform integration is needed for artificial intelligence to make an impact in drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 29, 2018 Category: Drugs & Pharmacology Authors: Semion K. Saikin Christoph Kreisbeck Dennis Sheberla Jill S. Becker Aspuru-Guzik A. Source Type: research

Drug-based cancer therapy to overcome immune resistance by steering tumor evolution
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 29, 2018 Category: Drugs & Pharmacology Authors: Ariel Fern ández Source Type: research

Advances in distributed computing with modern drug discovery
Volume 14, Issue 1, January 2019, Page 9-22 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 28, 2018 Category: Drugs & Pharmacology Authors: Antonio Jes ús Banegas-Luna Baldomero Imbern ón Antonio Llanes Castro Alfonso P érez-Garrido Jos é Pedro Cerón-Carrasco Sandra Gesing Ivan Merelli Daniele D ’Agostino Horacio P érez-Sánchez Source Type: research

Advances in distributed computing with modern drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 28, 2018 Category: Drugs & Pharmacology Authors: Antonio Jes ús Banegas-Luna Baldomero Imbern ón Antonio Llanes Castro Alfonso P érez-Garrido Jos é Pedro Cerón-Carrasco Sandra Gesing Ivan Merelli Daniele D ’Agostino Horacio P érez-Sánchez Source Type: research

Advances and challenges in drug design against tuberculosis: application of in silico approaches
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 27, 2018 Category: Drugs & Pharmacology Authors: Alexey Aleksandrov Hannu Myllykallio Source Type: research

Current developments in lantibiotic discovery for treating Clostridium difficile infection
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 27, 2018 Category: Drugs & Pharmacology Authors: Stephanie Kate Sandiford Source Type: research

Advances and challenges in drug design against tuberculosis: application of in silico approaches
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 27, 2018 Category: Drugs & Pharmacology Authors: Alexey Aleksandrov Hannu Myllykallio Source Type: research

Current developments in lantibiotic discovery for treating Clostridium difficile infection
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 27, 2018 Category: Drugs & Pharmacology Authors: Stephanie Kate Sandiford Source Type: research

Steps to address anti-microbial drug resistance in today ’s drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 23, 2018 Category: Drugs & Pharmacology Authors: Tanya Parish Source Type: research

Vortioxetine: a novel antidepressant for the treatment of major depressive disorder
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 20, 2018 Category: Drugs & Pharmacology Authors: Xenia Gonda Samata R. Sharma Frank I. Tarazi Source Type: research

Using virtual reality for drug discovery: a promising new outlet for novel leads
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 20, 2018 Category: Drugs & Pharmacology Authors: Xiao-Huan Liu Tao Wang Jian-Ping Lin Mian-Bin Wu Source Type: research

Vortioxetine: a novel antidepressant for the treatment of major depressive disorder
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 20, 2018 Category: Drugs & Pharmacology Authors: Xenia Gonda Samata R. Sharma Frank I. Tarazi Source Type: research

Using virtual reality for drug discovery: a promising new outlet for novel leads
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 20, 2018 Category: Drugs & Pharmacology Authors: Xiao-Huan Liu Tao Wang Jian-Ping Lin Mian-Bin Wu Source Type: research

An overview of neural networks for drug discovery and the inputs used
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 17, 2018 Category: Drugs & Pharmacology Authors: Yinqiu Xu Hequan Yao Kejiang Lin Source Type: research

Chromones: privileged scaffolds for the production of multi-target-directed-ligand agents for the treatment of Alzheimer ’s disease
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 15, 2018 Category: Drugs & Pharmacology Authors: Carlos F. M. Silva Diana C. G. A. Pinto Artur M. S. Silva Source Type: research

Developments with 3D bioprinting for novel drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 2, 2018 Category: Drugs & Pharmacology Authors: Aishwarya Satpathy Pallab Datta Yang Wu Bugra Ayan Ertugrul Bayram Ibrahim T. Ozbolat Source Type: research

Current approaches for choosing feature selection and learning algorithms in quantitative structure –activity relationships (QSAR)
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - October 29, 2018 Category: Drugs & Pharmacology Authors: Pathan Mohsin Khan Kunal Roy Source Type: research

Gaussian accelerated molecular dynamics for elucidation of drug pathways
Volume 13, Issue 11, November 2018, Page 1055-1065 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - October 29, 2018 Category: Drugs & Pharmacology Authors: Apurba Bhattarai Yinglong Miao Source Type: research

Current approaches for choosing feature selection and learning algorithms in quantitative structure –activity relationships (QSAR)
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - October 29, 2018 Category: Drugs & Pharmacology Authors: Pathan Mohsin Khan Kunal Roy Source Type: research

Gaussian accelerated molecular dynamics for elucidation of drug pathways
Volume 13, Issue 11, November 2018, Page 1055-1065 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - October 29, 2018 Category: Drugs & Pharmacology Authors: Apurba Bhattarai Yinglong Miao Source Type: research

Challenges and ethical considerations for using cloned primates for human brain discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - October 26, 2018 Category: Drugs & Pharmacology Authors: Alan O. Trounson Andrew J. French Source Type: research

Animal models used to assess influenza antivirals
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - October 26, 2018 Category: Drugs & Pharmacology Authors: Edin J. Mifsud Celeste MK Tai Aeron C. Hurt Source Type: research

Challenges and ethical considerations for using cloned primates for human brain discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - October 26, 2018 Category: Drugs & Pharmacology Authors: Alan O. Trounson Andrew J. French Source Type: research

Preclinical discovery and development of colesevelam for the treatment of type 2 diabetes
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - October 19, 2018 Category: Drugs & Pharmacology Authors: Henriette Holst Nerild Mikkel Bring Christensen Filip Krag Knop Andreas Br ønden Source Type: research

Targeting adenosine A2A receptor antagonism for treatment of cancer
Volume 13, Issue 11, November 2018, Page 997-1003 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - October 19, 2018 Category: Drugs & Pharmacology Authors: Miles Congreve Giles A. Brown Alexandra Borodovsky Michelle L. Lamb Source Type: research

Preclinical discovery and development of colesevelam for the treatment of type 2 diabetes
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - October 19, 2018 Category: Drugs & Pharmacology Authors: Henriette Holst Nerild Mikkel Bring Christensen Filip Krag Knop Andreas Br ønden Source Type: research

Targeting adenosine A2A receptor antagonism for treatment of cancer
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - October 19, 2018 Category: Drugs & Pharmacology Authors: Miles Congreve Giles A. Brown Alexandra Borodovsky Michelle L. Lamb Source Type: research

How far have decision tree models come for data mining in drug discovery?
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - October 18, 2018 Category: Drugs & Pharmacology Authors: Verena Sch öning Felix Hammann Source Type: research

Development of transplant immunosuppressive agents – considerations in the use of animal models
Volume 13, Issue 11, November 2018, Page 1041-1053 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - October 18, 2018 Category: Drugs & Pharmacology Authors: Russell Costello Adrien Kissenpfennig Paulo N Martins James McDaid Source Type: research